BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 30071306)

  • 1. The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial.
    Bacchetta J; Wesseling-Perry K; Kuizon B; Pereira RC; Gales B; Wang HJ; Elashoff R; Salusky IB
    Clin J Am Soc Nephrol; 2013 May; 8(5):824-32. PubMed ID: 23559676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2 years in children with Hurler or Hunter syndrome.
    Polgreen LE; Thomas W; Orchard PJ; Whitley CB; Miller BS
    Mol Genet Metab; 2014 Feb; 111(2):101-6. PubMed ID: 24368158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation induces stunting by lowering bone mass via GH/IGF-1 inhibition in very preterm infants.
    Cuestas E; Hillman M; Galetto S; Gaido MI; Sobh V; Damico LT; Rizzotti A
    Pediatr Res; 2023 Sep; 94(3):1136-1144. PubMed ID: 36941338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Habitual levels of physical activity influence bone mass in 11-year-old children from the United Kingdom: findings from a large population-based cohort.
    Tobias JH; Steer CD; Mattocks CG; Riddoch C; Ness AR
    J Bone Miner Res; 2007 Jan; 22(1):101-9. PubMed ID: 17014381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated maternal ultraviolet B exposure levels in pregnancy influence skeletal development of the child.
    Sayers A; Tobias JH
    J Clin Endocrinol Metab; 2009 Mar; 94(3):765-71. PubMed ID: 19116232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Density, Osteocalcin and Deoxypyridinoline for Early Detection of Osteoporosis in Obese Children.
    El-Dorry G; Ashry H; Ibrahim T; Elias T; Alzaree F
    Open Access Maced J Med Sci; 2015 Sep; 3(3):413-9. PubMed ID: 27275260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Observational Study on Response to Growth Hormone Therapy in Indian Patients of Short Stature with Special Emphasis on Biochemical Parameters and Bone Biomarkers.
    Roy R; Hazra A; Ghosh S
    Indian J Endocrinol Metab; 2023; 27(3):260-269. PubMed ID: 37583404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four year nutritional follow up after living related small bowel transplantation between monozygotic twins.
    Genton L; Raguso CA; Berney T; Hans DB; Morel P; Pichard C
    Gut; 2003 May; 52(5):659-62. PubMed ID: 12692049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Insulin-like Growth Factor-1 with Bone Mineral Density in Survivors of Childhood Acute Leukemia.
    Kim S; Yoo JW; Lee JW; Jung MH; Cho B; Suh BK; Ahn MB; Chung NG
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone densitometry: assessing the effects of growth hormone treatment in adults.
    Ortolani S
    Horm Res; 2000; 54 Suppl 1():19-23. PubMed ID: 11146375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of growth hormone status on body composition and the skeleton.
    Mukherjee A; Murray RD; Shalet SM
    Horm Res; 2004; 62 Suppl 3():35-41. PubMed ID: 15539797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation of bone acquisition during growth hormone treatment in children can be explained by proteomic biomarkers, bone formation markers, body composition and nutritional factors.
    Swolin-Eide D; Andersson B; Hellgren G; Magnusson P; Albertsson-Wikland K
    Bone; 2018 Nov; 116():144-153. PubMed ID: 30071306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
    Boot AM; Nauta J; de Jong MC; Groothoff JW; Lilien MR; van Wijk JA; Kist-van Holthe JE; Hokken-Koelega AC; Pols HA; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term changes in bone formation markers following growth hormone (GH) treatment in short prepubertal children with a broad range of GH secretion.
    Andersson B; Swolin-Eide D; Magnusson P; Albertsson-Wikland K
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):91-9. PubMed ID: 24818653
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.